Ha, Kim, Park, and Jung: Papillary thyroid microcarcinoma in a thyroid pyramidal lobe

Abstract

We report an extremely rare case of papillary thyroid microcarcinoma (PTMC) in the thyroid pyramidal lobe (TPL). A 48-year-old woman underwent ultrasound-guided fine-needle aspiration for a small thyroid nodule in the right lobe in local clinic, and it revealed a malignant cytology. On preoperative ultrasonography for tumor staging in our hospital, another small suspiciously malignant hypoechoic nodule was detected in the left TPL. Total thyroidectomy and central nodal dissection were performed. Histopathology confirmed PTMCs in the left TPL and both thyroid lobes. Ultrasonography for TPL should be required for complete evaluation of possible multifocality of thyroid malignancy.

Introduction

The third lobe of the thyroid gland is known as the thyroid pyramidal lobe (TPL). Based on autopsyand surgery-based studies, its prevalence ranges from 45% to 75% [1-3]. Complete removal of the thyroid tissue is generally a mandatory component of total thyroidectomy [1]. Most TPL can be fully excised during thyroid surgery, but TPLs that are located especially high in the neck, may escape notice [1,4]. A missed TPL may present as scintigraphic residue after total thyroidectomy, and radioisotope therapy may be required for any remnant thyroid tissue [1,5].
Thyroid ultrasonography (US) has been widely used in the evaluation of thyroid nodules, resulting in the establishment of certain characteristics that indicate benign and malignant thyroid nodules [6]. In general, US findings suggestive of a malignant thyroid nodule include marked hypoechogenicity, spiculated margin, microcalcifications, and a taller-than-wide shape [6,7]. In the literature, only a few reports regarding malignant tumors arising from the TPL have been found [8,9]. To the best of our knowledge, however, US detection of malignant tumors arising from the TPL has not been reported. Herein, we report a case of primary papillary thyroid microcarcinoma (PTMC) in the TPL, which was detected on preoperative US.

Case Report

In June 2013, a 48-year-old woman received a preoperative thyroid US for tumor staging in our hospital. Before 2 weeks, she underwent US-guided fine-needle aspiration biopsy for a small, suspicious malignant thyroid nodule in the right lobe in local clinic, and it revealed a malignant cytology. The patient showed normal values on a thyroid function test (T3, 104.4 ng/dL; free T4, 1.17 ng/dL; thyroid-stimulating hormone, 3.61 mIU/L), and no specific abnormalities were detected on a physical examination of the neck. The patient had previously undergone a left partial thyroidectomy at another hospital, because of a palpable thyroid mass that had the histological features of nodular hyperplasia. Subsequent to the partial thyroidectomy, the patient had not received any clinical or US follow-up at our hospital.
A preoperative thyroid US revealed two suspicious small malignant thyroid nodules in the left TPL (4.1 mm in the longest dimension) and right mid-lobe (3.6 mm in the longest dimension), a small hypoechoic nodule in the left mid-lobe (about 2.0 mm), and there was no grossly defined metastatic lymph nodes (Fig. 1AC). Because of known cytologically determined, malignant thyroid nodule in the right lobe, she did not undergo an ultrasound-guided fine-needle aspiration biopsy for a suspicious small thyroid nodule in the left TPL. Total thyroidectomy and central compartment neck dissection were performed without complications. Histopathologic investigation confirmed two PTMCs in the left TPL and right thyroid lobe (Fig. 1D, E), which corresponded to the US findings. The small hypoechoic nodule that was detected in the left thyroid lobe was confirmed to be a PTMC (Fig. 1F). No nodal metastases were found in the central neck. Chronic lymphocytic thyroiditis was evident in the entire thyroid tissue. The patient was discharged after surgery without radioiodine therapy. Follow-ups are regularly conducted with the patient (most recent follow-up: September 2013), and she is receiving hormone therapy for thyroid-stimulating hormone suppression without any complications.

Discussion

The thyroid gland is one of the largest endocrine gland, and comprises two lateral lobes that are connected along the median line by an isthmus, as well as the TPL, which extends superiorly from the isthmus of the thyroid gland [1,2]. The TPL appears to be related to the distal portion of the thyroglossal duct, an embryological structure, which initially develops along the migratory path of the thyroid gland and usually disappears during later development [3]. Most autopsy- or surgery-based studies have reported that a TPL is present in more than 50% of the general population [1-3], but a study using computed tomography has demonstrated that the prevalence of TPL is 44.6% in South Korea [10]. To date, no USbased studies of TPL prevalence have been published.
Malignant tumors arising from TPL are rare. Two cases of malignant nodules in the TPL have been described in the literature [8,9]. The first was a follicular thyroid carcinoma, which was surgically resected because of an increase in the size of the palpable cervical mass [8]. The second was a recurrent papillary thyroid carcinoma after total thyroidectomy [9]. In this report, we have described US and histopathological findings of primary PTMC in the left TPL and associated multifocal PTMCs in both thyroid lobes, which were incidentally detected on thyroid US.
Multifocality is a relatively common feature of PTMC; the prevalence of multifocality in papillary thyroid carcinomas ranges from 10% to 62% [11]. The TPL can be the origin or recurrent site of papillary thyroid carcinomas. Besides its role as a primary and secondary site of thyroid malignancy, the TPL is clinically interesting because of its importance to Graves disease and the efficacy of radioactive iodine therapy. Particularly, hyperthyroidism can recur after surgical removal of thyroid tissue if the TPL is not itself excised. Furthermore, remnant TPL can absorb most 131I and thereby nullify the benefit of postoperative radioactive iodine therapy [5].
In summary, we have reported the successful surgical resection of primary PTMC in the TPL and associated multifocal PTMCs in both thyroid lobes. US for TPL should be included for complete evaluation of possible multifocality of thyroid malignancy.

Notes

No potential conflict of interest relevant to this article was reported.

References

1. Braun EM, Windisch G, Wolf G, Hausleitner L, Anderhuber F. The pyramidal lobe: clinical anatomy and its importance in thyroid surgery. Surg Radiol Anat. 2007; 29:21–27.
[CrossRef] [PDF] [Google Scholar]
2. Prakash, Rajini T, Ramachandran A, Savalgi GB, Venkata SP, Mokhasi V. Variations in the anatomy of the thyroid gland: clinical implications of a cadaver study. Anat Sci Int. 2012; 87:45–49.
[CrossRef] [PDF] [Google Scholar]
3. Mohebati A, Shaha AR. Anatomy of thyroid and parathyroid glands and neurovascular relations. Clin Anat. 2012; 25:19–31.
[CrossRef] [Google Scholar]
4. Geraci G, Pisello F, Li Volsi F, Modica G, Sciume C. The importance of pyramidal lobe in thyroid surgery. G Chir. 2008; 29:479–482.
[Google Scholar]
5. Pacini F, Schlumberger M, Harmer C, Berg GG, Cohen O, Duntas L, et al. Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report. Eur J Endocrinol. 2005; 153:651–659.
[CrossRef] [Google Scholar]
6. Moon WJ, Baek JH, Jung SL, Kim DW, Kim EK, Kim JY, et al. Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations. Korean J Radiol. 2011; 12:1–14.
[CrossRef] [Google Scholar]
7. Kim DW, Park JS, In HS, Choo HJ, Ryu JH, Jung SJ. Ultrasoundbased diagnostic classification for solid and partially cystic thyroid nodules. AJNR Am J Neuroradiol. 2012; 33:1144–1149.
[CrossRef] [Google Scholar]
8. Ogawa C, Kammori M, Onose H, Yamada E, Shimizu K, Yamada T. Follicular carcinoma arising from the pyramidal lobe of the thyroid. J Nippon Med Sch. 2009; 76:169–172.
[CrossRef] [Google Scholar]
9. Lee YS, Kim KJ, Kim BW, Chang HS, Park CS. Recurrence of papillary thyroid carcinoma in a remnant pyramidal lobe. ANZ J Surg. 2011; 81:304.
[CrossRef] [Google Scholar]
10. Kim DW, Jung SL, Baek JH, Kim J, Ryu JH, Na DG, et al. The prevalence and features of thyroid pyramidal lobe, accessory thyroid, and ectopic thyroid as assessed by computed tomography: a multicenter study. Thyroid. 2013; 23:84–91.
[CrossRef] [Google Scholar]
11. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery. 1992; 112:1139–1146.
[Google Scholar]

Fig. 1.

Papillary thyroid microcarcinoma in the left thyroid pyramidal lobe of a 48-year-old woman.

Gray-scale ultrasonograms of thyroid gland (A, transverse; B, longitudinal) reveal a small hypoechoic nodule in the left thyroid pyramidal lobe (arrow, 2.6×2.7×4.1 mm). C. Transverse gray-scale ultrasonogram shows a small suspiciously malignant thyroid nodule with taller-than-wide shape and hypoechogenicity in right thyroid lobe (arrow, 2.4×2.6×3.6 mm) (known malignant cytology in local clinic). D. Gross specimen of thyroid pyramidal lobe shows a small ill-defined infiltrating mass lesion (arrow). E. Histological investigation reveals that papillary thyroid microcarcinoma in the thyroid pyramidal lobe, composed of neoplastic cells with papillary structures and intervening sclerotic stroma (H&E, ×200). F. Schematic drawing of the location of surgically confirmed papillary thyroid microcarcinomas (black circles) in the thyroid gland.
usg-14026-f1.tif

Formats

PDF LinksPDF(1.7M)EpubePub
PubReaderPubReader
Download Citation
METRICS Graph View

2,004

View

20

Save

1

Cited-By